Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Futu Holdings Ltd (FUTU) vs Novo Nordisk A/S (NVO) Price & Performance

Futu Holdings LtdTrade
Novo Nordisk A/STrade

Price performance (Past 24H)

Key statistics

Futu Holdings Ltd vs Novo Nordisk A/S — how do they compare? Futu Holdings Ltd trades at $105.95 (market cap $14.74B), while Novo Nordisk A/S trades at $45.88 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 14.1× Futu Holdings Ltd's market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.

FUTUNVO
Market Cap
$14.74B$207.85B
Sector
FinancialsHealth
52-Week High
$199.04$63.98
52-Week Low
$89.76$35.29
Enterprise Value
$14.59B$222.55B
Dividend Yield
2.47%3.81%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Futu Holdings Ltd

Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.

Read more on FUTU

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO